| Breast Cancer |
1 |
1 |
| Biologic Therapy |
0 |
0.9 |
| Cancer |
0 |
0.74 |
| Advanced and Metastatic Breast Cancer |
0 |
0.62 |
| Cancer Vaccine |
0 |
0.99 |
| Metastasis |
0 |
0.56 |
| Squamous Cell Carcinoma |
0 |
0.55 |
| Vaccines |
0 |
0.54 |
| Tumor |
0 |
0.48 |
| Toxicology |
0 |
0.45 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.43 |
| Genomic Medicine |
0 |
0.42 |
| Influenza |
0 |
0.37 |
| Patient Safety |
0 |
0.34 |
| Breast |
0 |
0.3 |
| Indolent Lymphoma |
0 |
0.24 |
| Chemotherapy |
0 |
0.21 |
| Lymphoma |
0 |
0.18 |
| B-Cell Lymphoma |
0 |
0.15 |
| Care and Maintenance of Vision |
0 |
0.15 |
| Follicular Lymphoma |
0 |
0.15 |
| Cataract |
0 |
0.13 |
| A-Scan Biometry |
0 |
0.12 |
| Radiation Therapy |
0 |
0.12 |
| Scan |
0 |
0.12 |
| Immunotherapy |
0 |
0.09 |
| Antigens |
0 |
0.06 |
| Intravenous |
0 |
0.06 |
| New York |
0 |
0.06 |
| Remission |
0 |
0.06 |
| Multiple Myeloma |
0 |
0.05 |
| Stem Cell Research and Therapy |
0 |
0.05 |
| Adrenal Metastases |
0 |
0.04 |
| Adverse Effects |
0 |
0.03 |
| Cervical Region |
0 |
0.03 |
| Clinical Research |
0 |
0.03 |
| Colitis |
0 |
0.03 |
| Fever |
0 |
0.03 |
| Finger |
0 |
0.03 |
| Geriatrics |
0 |
0.03 |
| Healthcare and Medical Technology |
0 |
0.03 |
| Hematology |
0 |
0.03 |
| Inflammatory Bowel Disease |
0 |
0.03 |
| Medical Oncology |
0 |
0.03 |
| Nausea |
0 |
0.03 |
| Pedal |
0 |
0.03 |
| Quality of Life |
0 |
0.03 |
| Scar |
0 |
0.03 |
| Sternum |
0 |
0.03 |
| Surgery |
0 |
0.03 |
| Tissue |
0 |
0.03 |
| Transplantation |
0 |
0.03 |